senior research scholars in china cdcs national immunization program CORD-Papers-2022-06-02 (Version 1)

Title: Senior Research Scholars in China CDCs National Immunization Program
Published: 2021-10-22
Journal: China CDC Wkly
DOI: 10.46234/ccdcw2021.223
DOI_URL: http://doi.org/10.46234/ccdcw2021.223
Author Name: Wang Miao
Author link: https://covid19-data.nist.gov/pid/rest/local/author/wang_miao
Author Name: Liu Yanmin
Author link: https://covid19-data.nist.gov/pid/rest/local/author/liu_yanmin
Author Name: Yan Tingting
Author link: https://covid19-data.nist.gov/pid/rest/local/author/yan_tingting
Author Name: Rodewald Lance
Author link: https://covid19-data.nist.gov/pid/rest/local/author/rodewald_lance
Author Name: An Zhijie
Author link: https://covid19-data.nist.gov/pid/rest/local/author/an_zhijie
Author Name: Yin Zundong
Author link: https://covid19-data.nist.gov/pid/rest/local/author/yin_zundong
sha: fb5612651163ddab02d8e22cd8a2639b07677263
license: cc-by-nc-sa
license_url: https://creativecommons.org/licenses/by-nc-sa/2.0/
source_x: Medline; PMC
source_x_url: https://www.medline.com/https://www.ncbi.nlm.nih.gov/pubmed/
pubmed_id: 34745690
pubmed_id_url: https://www.ncbi.nlm.nih.gov/pubmed/34745690
pmcid: PMC8563331
pmcid_url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563331
url: https://www.ncbi.nlm.nih.gov/pubmed/34745690/ https://doi.org/10.46234/ccdcw2021.223
has_full_text: TRUE
Keywords Extracted from Text Content: coronavirus disease 2019 provincial/prefectural-level CDCs SRSP adolescents COVID-19 vaccines Academician George F. CDCs Vice-Senior NIP-SRSP English language oral poliovirus children poliovirus early-to-mid-career provincial/prefectural early-tomid-career PLADs COVID-19 AEFI
Extracted Text Content in Record: First 5000 Characters:China CDC's National Immunization Program's Senior Research Scholars Program (NIP-SRSP) is a program created to foster the professional development of early-to-mid-career immunization experts, strengthen knowledge exchange and cooperation between national and provincial/prefectural-level CDCs, and deepen scientific and programmatic capacity of the National Immunization Program and provincial/prefectural immunization programs. Initiated in September 2019, the NIP-SRSP recruits immunization professionals for a 12-to-18-month experience in Beijing who have worked at the Vice-Senior professional level or above and are recommended by their provincial/prefectural CDC supervisor and leadership. The first cohort of National Immunization Program Senior Research Scholars successfully completed the program and were recognized by CDC Director, Academician George F. Gao at a commencement ceremony on August 25, 2021. The program selection process is designed to ensure a good match between scholars' professional development interests and the national and provincial/prefectural immunization program needs and project opportunities. Selection starts with recommendations from prospective scholars' CDC supervisors and leadership. Successful candidates have a deep affinity for their career in immunization with fulfilling working experiences, excellent interpersonal skills, and strong teamwork spirit, and they are well organized and motivated to contribute to the mission of the National Immunization Program while in Beijing and to their home CDC upon completion of the program. Scholars must be less than 45 years of age when they start the program and have good English language skills. Their work experience should include conducting and managing studies and research projects. SRSP combines theory and practice into a 12-to-18month full-time experience in Beijing that includes weekly immunization seminars; participating and teaching in conferences on infectious diseases, vaccines, epidemiology, evidence-based medicine, and pharmacovigilance; and participation in the Chinese Vaccinology Course (CNVAC), which is organized by the University of Chinese Academy of Sciences (with a curriculum that includes a global overview of vaccines, immunization strategies for prevention and control of vaccine-preventable diseases, vaccine development and preclinical research, vaccine production processes and analytics, vaccine regulation, immunization policy making, challenges of immunization and vaccinology, and communications with the public and media). Scholars complete one or more scientific or programmatic projects that align professional background, training needs, and goals of the scholar with the needs of the National Immunization Program. Scholars will be assigned to the appropriate branch of the immunization program for project mentorship and supervision. Currently, assignments are separated into three branches: 1) the Evidence-Based Decision-Making for Immunization Branch, which provides scientific support for the Technical Working Groups of the National Immunization Advisory Committee (NIAC) by conducting research on the methodology of evidence-based decision-making for immunization planning and providing methodological support for the formulation of technical guidelines for immunization; 2) the Vaccination and Immunization Services Branch, which conducts vaccination coverage surveillance, evaluation of vaccination service technologies, Immunization Information System development and use, programmatic policy and strategy development, technical guidelines and standards development, and school entry vaccination record check guidelines and evaluation; and 3) the Adverse Event Following Immunization (AEFI) Surveillance Branch, which conducts pharmacovigilance on all aspects of vaccine safety through a rigorous safety monitoring program jointly managed by China CDC and the National Medical Products Administration, identification and analysis of potential vaccine safety signals, formulation of vaccine safety technical guidelines, and monitoring vaccine-related public opinion. Du Wen from Guizhou Provincial CDC and Wu Jing from Jiangxi Provincial CDC are the first graduates of this new program. Du Wen matched with the AEFI Branch to work with Dr. Li Keli, the branch chief. Ms. Du worked on the following: 1) monitoring the safety of China's new coronavirus disease 2019 (COVID-19) vaccines while they were under the Emergency Use Authorization in preparation for routine use; 2) evaluation of the National Regulatory Authority for vaccines to strengthen the capacity of AEFI surveillance and ensure that China meets or exceeds the World Health Organization's quality criteria; 3) updating the national AEFI surveillance guidelines with the most recent scientific evidence on vaccine safety monitoring; and 4) upgrading AEFI surveillance modules in Immunization Information Systems. Wu Jing matched with the Vaccination and Immunization Services Branch to wo
PDF JSON Files: document_parses/pdf_json/fb5612651163ddab02d8e22cd8a2639b07677263.json
G_ID: senior_research_scholars_in_china_cdcs_national_immunization_program